摘要2021年7月，欧洲甲状腺学会/欧洲Graves眼病专家组(EUGOGO)在2016版的基础上更新发布了Graves眼病(Graves′ orbitopathy，GO)管理指南。新指南基于最新循证医学证据并对文献进行系统回顾，对新发现的危险因素、伴GO患者的甲状腺功能管理、中重度活动性突眼的一线和二线治疗选择、新型冠状病毒肺炎疫情下GO管理等问题进行了详细阐述、修订或内容增补。新指南给出32条明确推荐和4个疾病管理路径以期规范诊断、治疗及有效预防GO。

abstractsIn July 2021, the European Thyroid Association/European Group (EUGOGO) on Graves′Orbitopathy (GO) updated and published the Practice Guidelines on the basis of 2016 edition. The new guidelines made a systematic review of the literature and listed new risk factors, treatment of hyperthyroidism in patients with GO, the first-line and second-line therapy for moderate-to-severe and active GO and management of GO during COVID-19 pandemic in detail on the basis of latest evidence-based medicine. The editorial board proposed 32 specific recommendations and 4 algorithm for standardize diagnosis, treatment, and effective prevention of GO.